ArticleCureus2025
Temporal Effects of Tranexamic Acid Administration on Functional Endoscopic Sinus Surgery.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Functional endoscopic sinus surgery (FESS) is a commonly performed procedure, and tranexamic acid (TXA) has been shown to improve surgical outcomes. However, no previous studies have examined the time-dependent effects of TXA within the same patient during surgery. This study was conducted to address this gap. Methods This study included patients who underwent bilateral full-house FESS performed by a single surgeon at each institution. Patient demographics, operative times, and endoscopic scores for each side were retrospectively collected and analyzed. A within-patient design was used by comparing the first-operated side with the second-operated side during bilateral FESS. Results A total of 51 patients were included. The mean operative times for the first and second sides were 28 min 25 s and 28 min 49 s, respectively. The mean endoscopic scores were 1.4 and 1.5, respectively; these differences were not statistically significant. Patients were further stratified into eosinophilic chronic rhinosinusitis (ECRS) and non-ECRS groups to evaluate differences in operative time and endoscopic scores. No significant differences were found between the two groups. Conclusion Intravenous administration of 1000 mg TXA before surgery allowed bilateral full-house FESS to be performed with comparable quality on both sides. If the procedure is completed within the approximate 2-hour elimination half-life of TXA, additional or continuous administration may not be necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.